11 research outputs found

    A Low-Tech Analytical Method for Diethylcarbamazine Citrate in Medicated Salt

    Get PDF
    The World Health Organization has called for an effort to eliminate Lymphatic Filariasis (LF) around the world. In regions where the disease is endemic, local production and distribution of medicated salt dosed with diethylcarbamazine (DEC) has been an effective method for eradicating LF. A partner of the Notre Dame Haiti program, Group SPES in Port-au-Prince, Haiti, produces a medicated salt called Bon Sel. Coarse salt is pre-washed and sprayed with a solution of DEC citrate and potassium iodate. Iodine levels are routinely monitored on site by a titrimetric method. However, the factory had no method for monitoring DEC. Critical analytical issues include 1) determining whether the amount of DEC in each lot of Bon Sel is within safe and therapeutically useful limits, 2) monitoring variability within and between production runs, and 3) determining the effect of a common local practice (washing salt before use) on the availability of DEC. This paper describes a novel titrimetric method for analysis of DEC citrate in medicated salt. The analysis needs no electrical power and requires only a balance, volumetric glassware, and burets that most salt production programs have on hand for monitoring iodine levels. The staff of the factory used this analysis method on site to detect underloading of DEC on the salt by their sprayer and to test a process change that fixed the problem

    COVID‐19 vaccine controversy: A cross‐sectional analysis of factors associated with COVID‐19 vaccine acceptance amongst emergency department patients in New York City

    No full text
    Abstract Objective Understanding variables associated with coronavirus disease 2019 (COVID‐19) vaccine confidence and hesitancy may inform strategies to improve vaccine uptake in clinical settings such as the emergency department (ED). We aim to identify factors contributing to COVID‐19 vaccine acceptance and to assess patient attitudes surrounding offering COVID‐19 vaccines in the ED. Methods We conducted a survey of a convenience sample of patients and patient visitors over the age 18 years, who were native English or Spanish speakers. The survey was conducted from March through August 2021 at 3 EDs in New York City. The survey was administered via an electronic format, and participants provided verbal consent. Results Our sample size was 377. Individuals with post‐graduate degrees viewed vaccines positively (Prevalence Ratio [PR], 1.63; 95% Confidence Interval [CI], 1.07–2.47).  Of the various high‐risk medical conditions associated with adverse COVID‐19 infection outcomes, diabetes was the only condition associated with more positive views of vaccines (PR, 1.37; CI, 1.17–1.59). Of all participants, 71.21% stated that they believed offering a COVID‐19 vaccine in the ED was a good idea. Of unvaccinated participants, 21.80% stated they would get vaccinated if it were offered to them in the ED. Conclusion EDs can serve as a safety net for vulnerable populations and can act as an access point for vaccination

    Comparison of back-titration and HPLC concentration determinations.

    No full text
    <p>Error bars show standard deviation of triplicate measurements. For low concentration samples, error bars in HPLC measurement are very small.</p

    Within-lot and between-lot DEC citrate concentrations<sup>*</sup> in Bon Sel samples determined by titration method.

    No full text
    <p>*Different samples were taken from different bags of Bon Sel (see text for discussion of sample heterogeneity). The lots are approximately 500 kg in weight. Errors for each sample are the standard deviations for triplicate titration of the sample, except for X1, which was titrated 6 times. Lots 16–22 were analyzed by the titration method at Notre Dame, the other samples were analyzed in Haiti.</p

    DEC citrate standard curve for back titration.

    No full text
    <p>DEC concentration (g/100 g salt) versus endpoint volume of back-titration are plotted for triplicate standards.</p
    corecore